Delivery Order SPE2DB20D3103-SPE2DB25FM8T5

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $25,702.98 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 16, 2022 with a completion date of June 17, 2022. The contract is a delivery order issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a broad range of pharmaceutical products and...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $21,775.17. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,668.35 and was awarded on September 27, 2022, with an ultimate completion date of September 28, 2022. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $17,401.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 19, 2024 and was awarded on November 18, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $28,324.81, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order, with a period of performance through July 16, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite...
This federal contract award is for the delivery of Xarelto 20mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $7,036.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm-fixed-price delivery order with a completion date of January 19, 2024. The award was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $12,318.48 and an ultimate completion date of January 26, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award is for the delivery of Xarelto 20mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, awarded to AmerisourceBergen Drug Corp, is a delivery order with a firm fixed price of $26,097.95 and a period of performance ending on March 22, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides a wide range of...
This federal contract award is for the delivery of Xarelto 20mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $10,697.34. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. This award is associated with a larger...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $35,057.59 and is a firm fixed-price delivery order contract with a completion date of June 13, 2024. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM8T5
    Delivery Order

This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025, with a completion date of February 27, 2025. The contract has a firm fixed price of $27,525.24 and is a delivery order, not associated with a larger contract vehicle. The contract does not have a set-aside designation, indicating it was an open competition. AmerisourceBergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 5/28/25, 10:56 AM